Comparative pharmacokinetic study of neoral vs sandimmun in Japanese stable renal allograft recipients

By Takahara S.   Ohta K.   Ohashi Y.   Namii Y.   Uchida K.   Okuyama A.   Kainuma H.   Takagi H.   Takahashi K.   Morikawa H.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3089-3092

Elsevier

Access to resources Recommend Favorite

Comparative pharmacokinetic study of neoral versus sandimmun in Japanese stable renal allograft recipients

By Takahara S.   Ohta K.   Ohashi Y.   Namii Y.   Uchida K.   Okuyama A.   Kainuma H.   Takagi H.   Takahashi K.   Morikawa H.  

Transplantation Proceedings, Vol. 33, Iss. 4, 2001-06 ,pp. : 2541-2544

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of conversion from once daily sandimmun to twice daily neoral cyclosporine in renal allograft recipients

By Vathsala A.   Lee W.T.   Lu Y.-M.   Woo K.T.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1746-1748

Elsevier

Access to resources Recommend Favorite

The Swedish Nationwide Experience of Converting Transplant Patients Treated With Sandimmun to the New Galenic Formulation Sandimmun-Neoral

By Swedish Sandimmun-Neoral Conversion Group   Wilczek H.E.   Berglin E.   Blohme I.   Backman L.   Fehrman I.   Kallen R.   Nyberg G.   Sawe J.   Wahlberg J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 280-283

Elsevier

Access to resources Recommend Favorite

Pharmacodynamic monitoring of lymphocyte proliferation and TGF- 1 expression at cyclosporine a (CyA) trough levels (C 0 ) and 2 hours after intake (C 2 ) of CyA in human renal allograft recipients

By Bohler T.   Budde K.   Schneider M.   Eliazyfer S.   Dell K.   Einecke G.   Diekmann F.   Fritsche L.   Mai I.   Neumayer H.H.   Waiser J.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3148-3150

Elsevier

Access to resources Recommend Favorite